IL10 and neoplasm: Tumor-associated macrophages (TAMs) expressing M2 (alternatively activated)-like phenotype imitate type II T-helper cells that express interleukin (IL)-4, IL-5, IL-6, IL-13, and IL-10 to suppress anti-tumor immune response [120,121].